HOME >> BIOLOGY >> NEWS
Wistar scientists find striking similarities between bacterial virus and human adenovirus

Philadelphia--Scientists in the Wistar Institute laboratory of Roger M. Burnett, PhD., working in collaboration with scientists from the Department of Biosciences and Institute of Biotechnology at the University of Helsinki, Finland, have determined that the bacterial virus, PRD1, is strikingly similar, both biologically and architecturally, to adenovirus, a human virus commonly used as a transport system in gene therapy.

Specific details of this research appear the paper, "Viral evolution revealed by PRD1 and human adenovirus coat protein structures," published in the September 17, 1999 issue of the scientific journal, Cell.

Resemblances between these two double-stranded DNA viruses, which infect very different hosts, suggest an evolutionary relationship not previously observed. "We are very excited by this finding," explained Dr. Burnett, "since new research areas, including therapies, are always likely to open up when such parallels between different infective organisms are found."

According to Wistar graduate student, Stacy D. Benson, "this finding reinforces the similarities between different biological systems. In fact, we suspect that this same architecture will also be found in viruses that infect plants and simpler animals."

PRD1, discovered in the 1970s in the sewers of Kalamazoo, Michigan, infects bacteria found in the human digestive system. Because PRD1 is very small, 1/100th the width of a hair, various cross-disciplinary scientific tools, including electron microscopy and X-ray crystallography, were used to make detailed images of the virus.

Research on these structures was supported by grants from the National Institutes of Health, the National Science Foundation, the National Cancer Institute, the Fannie E. Rippel Foundation, the Technology Development Center of Finland and the Finnish Academy of Sciences.


'"/>

Contact: Diana Cutshall
dcutshall@wistar.upenn.edu
215-898-3716
The Wistar Institute
17-Sep-1999


Page: 1

Related biology news :

1. Wistar-discovered antibody will help diagnose appendicitis
2. 2004 Wistar Institute Science Journalism Award winners announced
3. Call for Entries: The 2004 Wistar Institute Science Journalism Award
4. Wistar-developed antibody shows promise against brain tumors in Drexel trial
5. Wistar study offers new support for a histone code theory of gene regulation
6. Regeneration in the mammalian heart demonstrated by Wistar researchers
7. Wistar scientists add difficult-to-sequence stretches to human genome data
8. Wistar scientist receives award from National Cancer Institute
9. Director of Emory Vaccine Center to give Wistar Institutes 1999 Tadeusz J. Wiktor Memorial lecture
10. Wistar Institute scientists find key piece in gene regulation puzzle
11. Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first ... insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and ... be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual ...
(Date:7/2/2020)... (PRWEB) , ... July 02, ... ... Biology Systems, B.V. (MBS) has announced a publication detailing the use of ... reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 2020 , ... Kerafast Inc. , developers of an ... availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed ... viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. ...
(Date:6/23/2020)... ... 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical company focused ... an Investigational New Drug application (IND) with the U.S. Food & Drug Administration ... NBTX-001 in patients with panic disorder (PD). , "Adding a PD trial to ...
(Date:6/11/2020)... GREENBELT, Md. (PRWEB) , ... June 09, 2020 ... ... announced today the release of the NEON Micro-Tracer Solution, a highly ... to the COVID-19 virus in the workplace. Contact tracing, a core disease control ...
(Date:5/30/2020)... (PRWEB) , ... May 29, 2020 , ... ... biotech, medical device, diagnostics, and animal health markets, has enabled Cytovale, Inc., a ... cell mechanics and machine learning, to achieve their first patient in (FPI) in ...
Breaking Biology Technology:
Cached News: